HMGCR and metabolic dysfunction-associated steatohepatitis: The finding of induced Hmgcr also indicates potential therapeutic strategy by statins, the Hmgcr-blocking drugs which indeed showed beneficial effects in NASH, a syndrome associated with increased incidence of liver iron deposition28.